UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050676
Receipt number R000057715
Scientific Title The median effective concentration of ropivacaine for ultrasound-guided suprainguinal fascia iliaca compartment block for preoperative pain management in elderly patients with hip fracture
Date of disclosure of the study information 2023/03/25
Last modified on 2024/02/01 11:22:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The median effective concentration of ropivacaine for ultrasound-guided suprainguinal fascia iliaca compartment block for preoperative pain management in elderly patients with hip fracture

Acronym

MEC of ropivacaine in SFICB

Scientific Title

The median effective concentration of ropivacaine for ultrasound-guided suprainguinal fascia iliaca compartment block for preoperative pain management in elderly patients with hip fracture

Scientific Title:Acronym

MEC of ropivacaine in SFICB

Region

Asia(except Japan)


Condition

Condition

Inpatients 75 years of age or older with acute hip fracture were recruited into the study.

Classification by specialty

Geriatrics Orthopedics Anesthesiology
Emergency medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aimed to evaluate the 50% effective concentration (ED50) of ropivacaine to achieve successful preperative pain management for ultrasound-guided suprainguinal fascia iliaca compartment blockade in elderly patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcomes was a successful analgesia (in the initial 24 hr after procedure, the exercising visual analog scale score < 4).

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

A concentration of 30 ml ropivacaine administered to the suprainguinal fascia iliaca compartment was measured by applying the up and down sequential method. The starting concentration was 0.35 % in the first patient, and increases or decreases in the concentration of ropivacaine were set at 0.025% on the basis of the response of the previous patient (effective or ineffective). The study was concluded when 7 crossovers occurred.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

75 years-old <

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

The inclusion criteria were patients 75 years of age or older with acute hip fracture.

Key exclusion criteria

The exclusion criteria were 1) weighing less than 35kg, 2) any serious systemic disease, 3) manifesting coagulopathy or receiving anticoagulants, 4) known hypersensitivity to ropivacaine, 5) a history of chronic pain or preoperative chronic use of analgesics, 6) an infection in the area where FICB was to be performed, 7) neurological or neuromuscular disease, and 8) dementia or having significant visual, hearing, or cognitive impairment.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name jie
Middle name
Last name Chen

Organization

Affiliated Banan Hospital of Chongqing Medical University

Division name

Department of Anaesthesiology

Zip code

401320

Address

Yunan Avenue 659, Longzhouwan Street, Banan District, Chongqing, China

TEL

+81-086-23-66234145

Email

cjandsh@tmmu.edu.cn


Public contact

Name of contact person

1st name jie
Middle name
Last name Chen

Organization

Affiliated Banan Hospital of Chongqing Medical University

Division name

Department of Anaesthesiology

Zip code

401320

Address

Yunan Avenue 659, Longzhouwan Street, Banan District, Chongqing, China

TEL

+81-086-23-66234145

Homepage URL


Email

cjandsh@tmmu.edu.cn


Sponsor or person

Institute

Department of Anaesthesiology, Affiliated Banan Hospital of Chongqing Medical University

Institute

Department

Personal name



Funding Source

Organization

Department of Anaesthesiology, Affiliated Banan Hospital of Chongqing Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of the Affiliated Banan Hospital of Chongqing Medical University

Address

Yunan Avenue 659, Longzhouwan Street, Banan District, Chongqing 401320, P.R China

Tel

+81-086-23-66291798

Email

409560509@qq.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

28

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 03 Month 17 Day

Date of IRB

2022 Year 11 Month 10 Day

Anticipated trial start date

2023 Year 04 Month 03 Day

Last follow-up date

2023 Year 10 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 25 Day

Last modified on

2024 Year 02 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057715


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name